[quote align=”center” color=”#999999″]
Being a part of the NIH OxCam program has allowed me to experience a range of very different global health research settings – from designing my project in a department in the hectic center of London (where most people never touch a pipet), to sorting intestinal worms by hand in rural villages in western Kenya, and now working in a lab at the NIH. Happily, the opportunity to learn about different cultures and world views has not decreased since I moved to Bethesda for the NIH portion of my project.
Alice Easton graduated summa cum laude from Princeton in 2009 with a degree in Ecology and Evolutionary Biology and a certificate in Public and International Affairs. Her thesis, written under the guidance of Prof. Simon A. Levin, examined the impact of HIV control interventions in southern India. A member of Phi Beta Kappa and Sigma Xi, Easton received the Adel Mahmoud Global Health Scholarship for undergraduate thesis research and the Sigma Xi Book Award for outstanding academic performance in Princeton’s Department of Ecology and Evolutionary Biology. After graduation, she joined the Center for Disease Dynamics, Economics and Policy in New Delhi as the India Coordinator for the Global Antibiotic Resistance Partnership. She returned to Chicago in October 2011 to join the Boston Consulting Group as an associate, where she focused on healthcare and operations research.
As an NIH-Marshall Scholar, Alice designed a field study to examine the sources and implications of variability in diagnostics for soil-transmitted helminths, secured ethical clearance in Kenya and the UK, and led a team of 20 people working in rural western Kenya over 1.5 years. Alice is currently analyzing the samples she collected in Kenya using qPCR for gastrointestinal parasites, 16S rRNA sequencing to examine microbial community structure, and whole genome sequencing to look at worm population genetics at the NIH. She plans to pursue a career at the interface of scientific research and public health, and hopes that her research will have an impact on the implementation of evidence-based disease control programs.